Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="VASTESAEGER, N" or (type exact bookEditor and editor="VASTESAEGER, N")

Mark
- conference
- C3
Comparing 2 referral strategies to diagnose axial spondyloarthritis: the recognizing and diagnosing ankylosing spondylitis reliably study

J Sieper, S Srinivasan, O Zamani, Herman Mielants (UGent) , D Choquette, K Pavelka, AG Loft, P Geher, D Danda, T Reitblat, et al.

(2011) ARTHRITIS AND RHEUMATISM. 63(10, suppl.). p.S199-S199
Mark
- conference
- C3
Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population

Bert Vander Cruyssen (UGent) , R WESTHOVENS, P DUREZ, L DE CLERCK, A PERETZ, L VERBRUGGEN, N VASTESAEGER, W NOEL and F DE KEYSER

(2008) RHEUMATOLOGY. 47.
Mark
- conference
- C3
Prediction models for disease: The effect of associations between markers on calculating the risk for disease by likelihood ratio products in SpA

Bert Vander Cruyssen (UGent) , Ruth Wittoek (UGent) , A BOONEN, Kurt De Vlam, N VASTESAEGER, W NOEL, Herman Mielants (UGent) and Filip De Keyser (UGent)

(2008) SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 37. p.33-33
Mark
- conference
- C3
Epidemiology of hip involvement in ankylosing spondylitis

Bert Vander Cruyssen (UGent) , E MUNOZ-GOMARIZ, P FONT, J MULERO, Kurt De Vlam, A BOONEN, W NOEL and N VASTESAEGER

(2008) CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 26(4). p.738-738
Mark
- conference
- C3
Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population

Bert Vander Cruyssen (UGent) , R WESTHOVENS, P DUREZ, Filip Van Den Bosch, Herman Mielants (UGent) , L DE CLERCK, A PERETZ, M MALAISE, L VERBRUGGEN, L DEWULF, et al.

(2008) SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 37. p.52-52
Mark
- journalArticle
- A1
- open access
Is the Allergic Rhinitis and its Impact on Asthma classification useful in daily primary care practice?

Helen Van Hoecke (UGent) , N VASTESAEGER, L DEWULF, Dirk De Bacquer (UGent) and Paul Van Cauwenberge (UGent)

(2006) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 118(3). p.758-759
Mark
- journalArticle
- A1
- open access
Classification and management of allergic rhinitis patients in general practice during pollen season

Helen Van Hoecke (UGent) , N Vastesaeger, L Dewulf, L Sys and Paul Van Cauwenberge (UGent)

(2006) ALLERGY. 61(6). p.705-711
Mark
- conference
- C3
Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Long-term clinical effect and prediction of attrition

Bert Vander Cruyssen (UGent) , R WESTHOVENS, P DUREZ, Filip Van Den Bosch, Herman Mielants (UGent) , L DE CLERCK, A PERETZ, M MALAISE, L VERBRUGGEN, N VASTESAEGER, et al.

(2006) ARTHRITIS AND RHEUMATISM. 54(9).
Mark
- journalArticle
- A1
Prediction of dose escalation for rheumatoid arthritis patients under infliximab treatment

Stijn Van Looy (UGent) , Bert Vander Cruyssen (UGent) , Jeroen Meeus, Bart Wyns (UGent) , R WESTHOVENS, P DUREZ, Filip Van Den Bosch, N VASTESAEGER, A GELDHOF, Luc Boullart (UGent) , et al.

(2006) ENGINEERING APPLICATIONS OF ARTIFICIAL INTELLIGENCE. 19(7). p.819-828
Mark
- journalArticle
- A1
Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity

Bert Vander Cruyssen (UGent) , Stijn Van Looy (UGent) , Bart Wyns (UGent) , R WESTHOVENS, P DUREZ, Filip Van Den Bosch, Herman Mielants (UGent) , L DE CLERCK, A PERETZ, M MALAISE, et al.

(2006) ARTHRITIS RESEARCH & THERAPY. 8(4).

Academic Bibliography

Comparing 2 referral strategies to diagnose axial spondyloarthritis: the recognizing and diagnosing ankylosing spondylitis reliably study

Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population

Prediction models for disease: The effect of associations between markers on calculating the risk for disease by likelihood ratio products in SpA

Epidemiology of hip involvement in ankylosing spondylitis

Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population

Is the Allergic Rhinitis and its Impact on Asthma classification useful in daily primary care practice?

Classification and management of allergic rhinitis patients in general practice during pollen season

Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Long-term clinical effect and prediction of attrition

Prediction of dose escalation for rheumatoid arthritis patients under infliximab treatment

Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity

Contents

Support

Contact